Reference39 articles.
1. Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor;Almeida;Clin. Pharmacokinet.,2013
2. Translational research for Parkinsons disease: the value of pre-clinical primate models;Badin;Eur. J. Pharmacol.,2015
3. Animal models of Parkinson's disease;Blandini;FEBS J.,2012
4. Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor;Bonifacio;Neuropharmacology,2014
5. Pharmacological profile of opicapone, a third generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat;Bonifácio;Br. J. Pharmacol.,2015
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献